The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy

NCT00807989 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2015-07-27

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy of usual monotherapy and low dose combination of Lamotrigine and Valproate. Low dose combination may be more effective and tolerable because they are low dose and VPA reduce Lamotrigine metabolism.

Conditions

Interventions

DRUG

Carbamazepine

DRUG

Lamotrigine/Valproate

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Byung-In Lee · Yonsei Univ.

  • Kyoung Heo · Yonsei Univ.

  • Sang-Kun Lee · Seoul National Univ.

  • Sang-Ahm Lee · Ulsan Univ.

  • Dong-Jin Shin · Gacheon Univ.

  • Hong-Ki Song · Hallym Univ.

  • Young-In Kim · Catholic Univ.

  • Se-Jin Lee · Youngnam Univ.

  • Sang-Ho Kim · Donga Univ.

  • Myung-Gyu Kim · Cheonnam Univ.

  • Yo-Sik Kim · Wonkwang Univ.

  • Sang-Do Lee · Dongsan Hosp.

  • Sung-Eun Kim · Pusan-Bak Hosp.

  • Sung-Pa Park · Kyungbuk Univ.

  • Joo-Yong Kim · Hanrim Univ.

  • Ok-Jun Kim · Bundang Cha

  • Soon-Ki Noh · Bong-Sang Hosp.

  • Hyang-Woon Lee · I-wha Univ.

  • Jae-Moon Kim · Chungnam Univ.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807989 on ClinicalTrials.gov